Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

FDA Approved a Total of 39 New Drugs in 2012 - Fifteen Year High

Marketwired February 15, 2013

ACADIA Pharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference on February 12, 2013

Business Wire February 5, 2013

Free Research Report on Opko Health, Inc., ACADIA Pharmaceuticals, Inc., Simcere Pharmaceutical Group, SciClone Pharmaceuticals, Inc. and Sequenom, Inc.

PR Newswire January 30, 2013

Free Research Reports on ACAD, CRUS, DAL and SBUX Issued by the Bedford Report

Marketwired January 25, 2013

ACADIA Pharmaceuticals Announces Election of Stephen R. Biggar to Its Board of Directors

Business Wire January 22, 2013

Our Pros Knew DELL, ACAD, FNP and HLF Would Be Top Gainers on Monday

Marketwired January 15, 2013

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Marketwired January 14, 2013

Perfect Trade Setups, How to Play CHTP, EDAP, ACAD and CHKR

Marketwired January 8, 2013

ACADIA Pharmaceuticals to Receive Funding from Fast Forward and EMD Serono for Multiple Sclerosis Program

Business Wire December 20, 2012